Associated Pathology in Case of Death from Circulatory Circulatory Diseases According to the Analysis of Multiple Causes

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Comorbidity of diseases deteriorates health and often increases the risk of death. Identification of comorbidities with diseases of the circulatory system (DCS) will help find additional measures to increase life expectancy. 

Aims — to identify causes associated with death from DCS and to analyze their interrelation based on the multiple cause analysis. 

Materials and methods. Data on DCS deaths of the Death registration in the Moscow Unified Medical Information and Analytical System (RFS-EMIAS) in 2019 (46 000 deaths) and from April to May 2020 (11 000 deaths) excluding perinatal mortality were analyzed. The association analysis was carried out across groups of the ICD-10 DCS blocks by calculating the corresponding frequency. Effect of SARS-CoV-2 was analyzed in the infected deceased and those free from infection. Comparison was carried out by the Chi-square test. 

Results. The following Diseases of the circulatory system are associated with Diabetes mellitus: Hypertension, Coronary heart disease, Cerebrovascular diseases, and Diseases of arteries, arterioles and capillaries. A synergetic effect has been identified in comorbidity with the diseases characterized by high blood pressure and Chronic rheumatic heart diseases, “other forms of heart disease”(I30–I52), Cerebrovascular diseases and Diseases of arteries, arterioles and capillaries; the latter and Coronary heart disease and Cerebrovascular diseases; “other forms of heart disease” and Mental disorders due to psychoactive substance use; Diseases of veins, lymphatic vessels and lymph nodes and Pulmonary circulation disorders. Effect of the increased risk of death in non-symmetric associations of causes has been detected for comorbidity of Diseases of veins, lymph vessels and lymph nodes and Chronic viral hepatitis; Coronary heart disease and “other forms of heart disease”; Hypertension and Coronary heart disease; in males – comorbidity of Obesity and Hypertension, and Diseases of arteries, arterioles and capillaries and Hypertension. Associations between DCS and their complications have been identified in females: Diseases of veins, lymph vessels and lymph nodes and Phlegmon, and Cerebrovascular diseases and Decubital ulcers. 

Conclusion. SARS-CoV-2 increases mortality from Chronic coronary heart disease, ICD-10 I67.8 code for Other specified cerebrovascular diseases and Hypertension in females 1.5-fold. The infection rate in females died from DCS is significantly lower compared to the one in males.

Full Text

Restricted Access

About the authors

Aleksandr V. Zubko

Federal Research Institute for Health Organization and Informatics; Institute for Demographic Research — Branch of the Federal Center of Theoretical and Applied Sociology

Author for correspondence.
Email: zubko@mednet.ru
ORCID iD: 0000-0001-8958-1400
SPIN-code: 6913-4828

MD, PhD

Russian Federation, 11 Dobrolubova str., 127254, Moscow; Moscow

Tamara P. Sabgayda

Research Institute of Medical Management and Health Organization; Federal Research Institute for Health Organization and Informatics; Institute for Demographic Research — Branch of the Federal Center of Theoretical and Applied Sociology

Email: tsabgaida@mail.ru
ORCID iD: 0000-0002-5670-6315
SPIN-code: 7925-6902

MD, PhD, Professor

Russian Federation, Moscow; 11 Dobrolubova str., 127254, Moscow; Moscow

Alla E. Ivanova

Research Institute of Medical Management and Health Organization; Institute for Demographic Research — Branch of the Federal Center of Theoretical and Applied Sociology

Email: ivanova-home@yandex.ru
ORCID iD: 0000-0002-0258-3479
SPIN-code: 7621-8398

PhD in Economics, Professor

Russian Federation, Moscow; Moscow

Galina N. Evdokushkina

Research Institute of Medical Management and Health Organization; Federal Research Institute for Health Organization and Informatics; Institute for Demographic Research — Branch of the Federal Center of Theoretical and Applied Sociology

Email: gnevdokushkina@gmail.com
ORCID iD: 0000-0002-1389-2509
SPIN-code: 1552-9943
Russian Federation, Moscow; 11 Dobrolubova str., 127254, Moscow; Moscow

Vyacheslav G. Zaporozhchenko

Federal Research Institute for Health Organization and Informatics

Email: zapvg@mednet.ru
ORCID iD: 0000-0002-6167-7379
SPIN-code: 5667-1756

MD, PhD

Russian Federation, 11 Dobrolubova str., 127254, Moscow

Vladimir I. Starodubov

Federal Research Institute for Health Organization and Informatics

Email: starodubov@mednet.ru
ORCID iD: 0000-0002-3625-4278
SPIN-code: 7223-9834

MD, PhD, Professor, Academician of the RAS

Russian Federation, 11 Dobrolubova str., 127254, Moscow

References

  1. Шальнова С.А., Драпкина О.М. Тренды смертности от болезней системы кровообращения и злокачественных новообразований у российских мужчин и женщин 2000–2016 гг. // Рациональная фармакотерапия в кардиологии. 2019. — Т. 15. — № 1. — С. 77–83. [Shalnova SA, Drapkina OM. The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years. Rational Pharmacotherapy in Cardiology. 2019;15(1):77–83. (In Russ.)] doi: https://doi.org/10.20996/1819-6446-2019-15-1-77-83
  2. Сабгайда Т.П., Семенова В.Г. Связь снижения сердечно-сосудистой смертности 2013–2015 годов с изменением смертности от других причин // Социальные аспекты здоровья населения. — 2017. — № 5. [Sabgayda TP, Semenova VG. Relationship between decline in cardiovascular mortality in 2013–2015 and change in mortality from other causes. Social aspects of population health. 2017;(5). (In Russ.)]. Available from: http://vestnik.mednet.ru/content/view/915/30/lang.ru (accessed: 05.09.2021). doi: https://doi.org/10.21045/2071-5021-2017-57-5-2
  3. Вишневский А.Г., Андреев Е.М., Тимонин С.А. Смертность от болезней системы кровообращения и продолжительность жизни в России // Демографическое обозрение. — 2016. — Т. 3. — № 1. — С. 6–34. [Vishnevsky AG, Andreev EM, Timonin SA. Mortality from cardiovascular diseases and life expectancy in Russia. Demographic Review. 2016;3(1):6–34. (In Russ.)]
  4. Redelings MD, Wise M, Sorvillo F. Using Multiple Cause-of-Death Data to Investigate Associations and Causality between Conditions Listed on the Death Certificate. Am J Epidemiol. 2007;166(1):104–108. doi: https://doi.org/10.1093/aje/kwm037
  5. Moreno-Betancur M, Sadaoui H, Piffaretti C, Rey G. Survival Analysis with Multiple Causes of Death: Extending the Competing Risks Model. Epidemiology. 2017;28(1):12–19. doi: https://doi.org/10.1097/EDE.0000000000000531
  6. Piffaretti C, Moreno-Betancur M, Lamarche-Vadel A, Rey G. Quantifying cause-related mortality by weighting multiple causes of death. Bull World Health Organ. 2016;94(12):870–879. doi: https://doi.org/10.2471/BLT.16.172189
  7. Désesquelles A, Grippo F, Egidi V, et al. Multi-morbidity and frailty at death: a new classification of death records for an aging world. 4th workshop of the Multicause network, May 2019, Paris, France. Available from: https://hal.archives-ouvertes.fr/hal-02419339. (accessed: 05.09.2021).
  8. Хромушин В.А. Методология анализа множественных причин смерти // Врач и информационные технологии. — 2004. — № 9. — С. 38–42. [Khromushin VA. Metodologiya analiza mnozhestvennykh prichin smerti. Vrach i informacionnye tehnologii = Physicians and IT. 2004;(9):38–42. (In Russ).]
  9. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–538. doi: https://doi.org/10.1007/s00392-020-01626-9
  10. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16–24 February 2020. Available from: https:// www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (аccessed: 09.03.2020).
  11. Барбараш О.Л., Каретникова В.Н., Кашталап В.В., и др. Новая коронавирусная болезнь (COVID-19) и сердечно-сосудистые заболевания // Комплексные проблемы сердечно-сосудистых заболеваний. — 2020. — Т. 9. — № 2. — С. 17–28. [Barbarash OL, Karetnikova VN, Kashtalap VV, et al. New coronavirus disease (COVID-19) and cardiovascular disease. Complex Issues of Cardiovascular Diseases. 2020;9(2):17–28. (In Russ.)] doi: https://doi.org/10.17802/2306-1278-2020-9-2-17-28
  12. Зубко А.В., Сабгайда Т.П. Оперативная активность по профилю сосудистой хирургии в медицинских организациях различного уровня // Социальные аспекты здоровья населения. — 2016. — № 6. [Zubko AV, Sabgayda TP. Vascular surgery in hospitals of different levels. Social aspects of population health. 2020;(6). (In Russ.)]. doi: https://doi.org/10.21045/2071-5021-2016-52-6-2
  13. Speizer FE, Trey C, Parker P. The uses of multiple causes of death data to clarify changing patterns of cirrhosis mortality in Massachusetts. Am J Public Health. 1977;67(4):333–336. doi: https://doi.org/10.2105/ajph.67.4.333
  14. He L, Mäe MA, Sun Y, et al. Pericyte-specific vascular expression of SARS-CoV-2 receptor ACE2 — implications for microvascular inflammation and hypercoagulopathy in COVID-19 patients. bioRxiv. 2020;05.11.088500. Available from: https://www.biorxiv.org/content/10.1101/2020.05.11.088500v2 (аccessed: 06.09.2021). doi: https://doi.org/10.1101/2020.05.11.088500
  15. Сабгайда Т.П., Иванова A.E., Семенова В.Г., и др. Изменение структуры инфекционной смертности в постсоветский период // Социальные аспекты здоровья населения. — 2020. — № 2. [Sabgayda TP, Ivanova AE, Semyonova VG, et al. Structural changes in mortality from infectious diseases in the post-Soviet Russia. Social aspects of population health. 2020;(3). (In Russ.)] Available from: http://vestnik.mednet.ru/content/view/1150/30/lang.ru (accessed: 06.09.2021). doi: https://doi.org/10.21045/2071-5021-2020-66-2-6
  16. Драпкина О.М., Самородская И.В., Старинская М.А., Бойцов С.А. Сравнение российских регионов по уровню стандартизованных коэффициентов смертности от всех причин и болезней системы кровообращения в 2006–2016 гг. // Профилактическая медицина. — 2018. — Т. 21. — № 4. — С. 4–12. [Drapkina OM, Samorodskaya IV, Starinskaya MA, Boytsov SA. Comparison of Russian regions by standardized mortality rates from all causes and circulatory system diseases in 2006–2016. The Russian Journal of Preventive Medicine. 2018;21(4):4–12. (In Russ.) doi: https://doi.org/10.17116/profmed20182144
  17. Lu Y, Hajifathalian K, Ezzati M, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383(9921):970–983. doi: https://doi.org/10.1016/S0140-6736(13)61836-X
  18. Moriyama IM, Loy RM, Robb-Smith AHT. History of the statistical classification of diseases and causes of death. Rosenberg HM, Hoyert DL, eds. Hyattsville, MD: National Center for Health Statistics; 2011. 66 р.
  19. Australian Institute of Health and Welfare. Multiple causes of death. An analysis of all natural and selected chronic disease causes of death 1997–2007. Bulletin 105. Cat. AUS 159. Canberra: AIHW; 2012. 36 p.
  20. Seuc AH, Fernández L, Mirabal-Sosa M, González CA. Cuban Application of Two Methods for Analyzing Multiple Causes of Death. MEDICC Rev. 2018;20(3):30–35. doi: https://doi.org/10.37757/MR2018.V20.N3.7

Copyright (c) 2021 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies